Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/8/2026

1. TTD
2. ABNB
3. NET
4. TEAM
5. FROG
6. DV
7. TWLO
8. CART
9. SPY
10. LYFT

Go back to Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
(NASDAQ: VTGN) Delayed: 0.29 +0.01 (3.57%)
Previous Close $0.28    52 Week High $4.60 
Open $0.29    52 Week Low $2.81 
Day High $0.31    P/E N/A 
Day Low $0.28    EPS $0.00 
Volume 2,555,764       

(NASDAQ: VTGN) Delayed: 0.29 +0.01 (3.57%)
Previous Close $0.28    52 Week High $4.60 
Open $0.29    52 Week Low $2.81 
Day High $0.31    P/E N/A 
Day Low $0.28    EPS $0.00 
Volume 2,555,764